Business
Why the Mesoblast (ASX:MSB) share price is charging higher today – The Motley Fool Australia
The Mesoblast limited (ASX:MSB) share price is pushing higher on Monday after providing an update on its remestemcel-L for the treatment of SR-aGVHD…
The Mesoblast limited(ASX: MSB) share price has started the week strongly and is charging higher.
In early trade the allogeneic cellular medicines company’s shares are up 3% to $4.45.
Why is the Mesoblast share price pushing higher?
Investors have been buying the company’s shares this morning after its revealed results from a study of its remestemcel-L product in children with steroid-refractory acute graft versus host disease (SR-aGVHD).
According to the release, the results provide in vivo biomarker…
-
Noosa News21 hours agoWas Sir Joh ‘God’, as David Littleproud says, or a template for Trump?
-
General20 hours agoAustralia urges de-escalation as US strikes Iran
-
General19 hours agoAustralian government calls for de-escalation of war in Iran as Coalition endorses US strikes
-
Noosa News21 hours agoNRL live updates: Brisbane Broncos vs Cronulla Sutherland Sharks, Sydney Roosters vs North Queensland Cowboys, Parramatta Eels vs Gold Coast Titans